The landscape of dementia diagnosis has evolved drastically with the appearance of innovative biomarkers, such as amyloid PET scans, tau imaging, and blood-centered exams that can detect Alzheimer's pathology yrs just before indications emerge. Whilst these technological improvements stand for exceptional progress in understanding neurodegenerative